Intralesional Vitamin D3 Versus Intralesional Acyclovir in Treatment of Plantar Warts

• Status: Not yet recruiting
• Trial end date: 2023-11-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate and compare the efficacy and safety of intralesional acyclovir versus intralesional vitamin D3 in the treatment of plantar warts

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Acyclovir; Vitamin D

Criteria

Inclusion Criteria:

• Adult participants of both sex with plantar warts will be included in the study

Exclusion Criteria:

• - Children < 12 years.

• Pregnant and lactating women.

• Receiving any treatment for warts within 1 month before the study.

• Systemic antiviral medication.

• Previous history of vitamin D or acyclovir hypersensitivity.

• Vitamin D supplementation.

• Concurrent other skin disorders.

• Immunosuppressive disorders or receiving immunosuppressive drugs.

• Receiving drugs that may alter vitamin D level including prednisone, orlistat, phenytoin and thiazide diuretics.